West Pharma (WST) Tops Q3 EPS by 4c; Boosts FY13 Outlook; Announces Stock Split
Tweet Send to a Friend
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q3 EPS of $0.86, $0.04 better than the analyst estimate of $0.82. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
